Skip to main content

Advertisement

SpringerLink
Log in

Radotinib-induced eruptive melanocytic nevi in patient with chronic myeloid leukemia: a case report and literature review

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Hutchinson J (1868) Outbreak of a large crop of moles. Remarks as to possible connection with melanosis. J Cutan Med Dis Skin 1:170–171

    Google Scholar 

  2. Amitay-Laish I, Stemmer SM, Lacouture ME (2011) Adverse cutaneous reactions secondary to tyrosine kinase inhibitors including imatinib mesylate, nilotinib, and dasatinib. Dermatol Ther 24(4):386–395. https://doi.org/10.1111/j.1529-8019.2011.01431.x

    Article  PubMed  Google Scholar 

  3. Arora B, Kumar L, Sharma A, Wadhwa J, Kochupillai V (2004) Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate. Ann Oncol 15(2):358–359

    Article  CAS  PubMed  Google Scholar 

  4. Bovenschen HJ, Tjioe M, Vermaat H, de Hoop D, Witteman BM, Janssens RW, Stoof TJ, van de Kerkhof PC (2006) Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. Br J Dermatol 154(5):880–884. https://doi.org/10.1111/j.1365-2133.2006.07189.x

    Article  CAS  PubMed  Google Scholar 

  5. Kim M, Yoon YH, Lee JH, Kim DW, Park HJ (2017) Eruptive melanocytic naevi caused by radotinib therapy in patients with chronic myeloid leukaemia: 10 cases and a literature review. Acta Derm Venereol 97(1):115–116. https://doi.org/10.2340/00015555-2475

    Article  CAS  PubMed  Google Scholar 

  6. Perry BM, Nguyen A, Desmond BL, Blattner CM, Thomas RS, Young RJ (2016) Eruptive nevi associated with medications (ENAMs). J Am Acad Dermatol 75(5):1045–1052. https://doi.org/10.1016/j.jaad.2016.04.064

    Article  PubMed  Google Scholar 

  7. Won KH, Jo SY, Lee YJ, Chang SE (2016) Radotinib-induced lentiginosis: a report of an adverse cutaneous reaction associated with a tyrosine kinase inhibitor. Clin Exp Dermatol 41(2):162–165. https://doi.org/10.1111/ced.12706

    Article  CAS  PubMed  Google Scholar 

  8. Woo YR, Kim JS, Kim DW, Park HJ (2017) Development of dysplastic nevus during radotinib therapy in patients with chronic myeloid leukemia. Indian J Dermatol Venereol Leprol 83(6):704–707. https://doi.org/10.4103/ijdvl.IJDVL_1030_16

    Article  PubMed  Google Scholar 

  9. Kwak JY, Kim SH, Oh SJ, Zang DY, Kim H, Kim JA, Do YR, Kim HJ, Park JS, Choi CW, Lee WS, Mun YC, Kong JH, Chung JS, Shin HJ, Kim DY, Park J, Jung CW, Bunworasate U, Comia NS, Jootar S, Reksodiputro AH, Caguioa PB, Lee SE, Kim DW (2017) Phase III clinical trial (RERISE study) results of efficacy and safety of Radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia. Clin Cancer Res 23(23):7180–7188. https://doi.org/10.1158/1078-0432.Ccr-17-0957

    Article  CAS  PubMed  Google Scholar 

  10. Eskazan AE, Keskin D (2017) Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update. Ther Adv Hematol 8(9):237–243. https://doi.org/10.1177/2040620717719851

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Veterans Health Service Medical Center, 53 Jinhwang-doro 61-gil, Gangdong-gu, Seoul, 05368, South Korea

    Eunjung Park & Mihn-Sook Jue

Authors
  1. Eunjung Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mihn-Sook Jue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mihn-Sook Jue.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, E., Jue, MS. Radotinib-induced eruptive melanocytic nevi in patient with chronic myeloid leukemia: a case report and literature review. Ann Hematol 98, 533–535 (2019). https://doi.org/10.1007/s00277-018-3444-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-018-3444-0

Search

Navigation